{"id":"https://openalex.org/W3092298396","doi":"https://doi.org/10.1111/bcpt.13517","title":"Prescribers' compliance with summary of product characteristics of dabigatran, rivaroxaban and apixaban\u2014A European comparative drug utilization study","display_name":"Prescribers' compliance with summary of product characteristics of dabigatran, rivaroxaban and apixaban\u2014A European comparative drug utilization study","publication_year":2020,"publication_date":"2020-10-10","ids":{"openalex":"https://openalex.org/W3092298396","doi":"https://doi.org/10.1111/bcpt.13517","mag":"3092298396","pmid":"https://pubmed.ncbi.nlm.nih.gov/33037766"},"language":"en","primary_location":{"id":"doi:10.1111/bcpt.13517","doi":"https://doi.org/10.1111/bcpt.13517","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bcpt.13517","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcpt.13517","source":{"id":"https://openalex.org/S44074210","display_name":"Basic & Clinical Pharmacology & Toxicology","issn_l":"1742-7835","issn":["1742-7835","1742-7843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Basic & Clinical Pharmacology & Toxicology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcpt.13517","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039118583","display_name":"Marietta Rottenkolber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Marietta Rottenkolber","raw_affiliation_strings":["Diabetes Research Group, Medizinische Klinik und Poliklinik IV, Klinikum der Universitaet Muenchen, Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetes Research Group, Medizinische Klinik und Poliklinik IV, Klinikum der Universitaet Muenchen, Munich, Germany","institution_ids":["https://openalex.org/I8204097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012267945","display_name":"Sven Schmiedl","orcid":"https://orcid.org/0000-0003-4844-0112","observed_orcids":["https://orcid.org/0000-0003-4844-0112"]},"institutions":[{"id":"https://openalex.org/I155976169","display_name":"Witten/Herdecke University","ror":"https://ror.org/00yq55g44","country_code":"DE","type":"education","lineage":["https://openalex.org/I155976169"]},{"id":"https://openalex.org/I4210120381","display_name":"Helios Universit\u00e4tsklinikum Wuppertal","ror":"https://ror.org/02r8sh830","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210120381"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Sven Schmiedl","raw_affiliation_strings":["Department of Clinical Pharmacology, School of Medicine, Faculty of Health, Witten/Herdecke University, Witten, Germany","Philipp Klee-Institute for Clinical Pharmacology, Helios University Hospital Wuppertal, Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, School of Medicine, Faculty of Health, Witten/Herdecke University, Witten, Germany","institution_ids":["https://openalex.org/I155976169"]},{"raw_affiliation_string":"Philipp Klee-Institute for Clinical Pharmacology, Helios University Hospital Wuppertal, Wuppertal, Germany","institution_ids":["https://openalex.org/I4210120381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088162585","display_name":"Luisa Ib\u00e1\u00f1ez","orcid":"https://orcid.org/0000-0002-1175-0574","observed_orcids":["https://orcid.org/0000-0002-1175-0574"]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Luisa Ib\u00e1nez","raw_affiliation_strings":["Fundaci\u00f3 Institut Catal\u00e0 de Farmacologia (FICF) Department of Clinical Pharmacology Department of Pharmacology, Toxicology and Therapeutics Hospital Universitari Vall d'Hebron Universitat Aut\u00f2noma de Barcelona Barcelona Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fundaci\u00f3 Institut Catal\u00e0 de Farmacologia (FICF) Department of Clinical Pharmacology Department of Pharmacology, Toxicology and Therapeutics Hospital Universitari Vall d'Hebron Universitat Aut\u00f2noma de Barcelona Barcelona Spain","institution_ids":["https://openalex.org/I123044942","https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087307902","display_name":"M\u00f2nica Sabat\u00e9","orcid":"https://orcid.org/0000-0001-6206-1085","observed_orcids":["https://orcid.org/0000-0001-6206-1085"]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"M\u00f2nica Sabat\u00e9","raw_affiliation_strings":["Fundaci\u00f3 Institut Catal\u00e0 de Farmacologia (FICF) Department of Clinical Pharmacology Department of Pharmacology, Toxicology and Therapeutics Hospital Universitari Vall d'Hebron Universitat Aut\u00f2noma de Barcelona Barcelona Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fundaci\u00f3 Institut Catal\u00e0 de Farmacologia (FICF) Department of Clinical Pharmacology Department of Pharmacology, Toxicology and Therapeutics Hospital Universitari Vall d'Hebron Universitat Aut\u00f2noma de Barcelona Barcelona Spain","institution_ids":["https://openalex.org/I123044942","https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036963616","display_name":"Elena Ballar\u00edn","orcid":"https://orcid.org/0000-0001-9786-6617","observed_orcids":["https://orcid.org/0000-0001-9786-6617"]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Elena Ballar\u00edn","raw_affiliation_strings":["Fundaci\u00f3 Institut Catal\u00e0 de Farmacologia (FICF) Department of Clinical Pharmacology Department of Pharmacology, Toxicology and Therapeutics Hospital Universitari Vall d'Hebron Universitat Aut\u00f2noma de Barcelona Barcelona Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fundaci\u00f3 Institut Catal\u00e0 de Farmacologia (FICF) Department of Clinical Pharmacology Department of Pharmacology, Toxicology and Therapeutics Hospital Universitari Vall d'Hebron Universitat Aut\u00f2noma de Barcelona Barcelona Spain","institution_ids":["https://openalex.org/I123044942","https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055091916","display_name":"Xavier Vidal","orcid":"https://orcid.org/0000-0001-6705-4298","observed_orcids":["https://orcid.org/0000-0001-6705-4298"]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Xavier Vidal","raw_affiliation_strings":["Fundaci\u00f3 Institut Catal\u00e0 de Farmacologia (FICF) Department of Clinical Pharmacology Department of Pharmacology, Toxicology and Therapeutics Hospital Universitari Vall d'Hebron Universitat Aut\u00f2noma de Barcelona Barcelona Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fundaci\u00f3 Institut Catal\u00e0 de Farmacologia (FICF) Department of Clinical Pharmacology Department of Pharmacology, Toxicology and Therapeutics Hospital Universitari Vall d'Hebron Universitat Aut\u00f2noma de Barcelona Barcelona Spain","institution_ids":["https://openalex.org/I123044942","https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091668757","display_name":"Luz Mar\u00eda Le\u00f3n-Mu\u00f1oz","orcid":"https://orcid.org/0000-0001-5447-5907","observed_orcids":["https://orcid.org/0000-0001-5447-5907"]},"institutions":[{"id":"https://openalex.org/I4210142787","display_name":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios","ror":"https://ror.org/043fs9135","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210098440","https://openalex.org/I4210142787"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Luz Mar\u00eda Leon\u2010Mu\u00f1oz","raw_affiliation_strings":["Pharmacoepidemiology and Pharmacovigilance Division, Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacoepidemiology and Pharmacovigilance Division, Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain","institution_ids":["https://openalex.org/I4210142787"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025489096","display_name":"Consuelo Huerta","orcid":"https://orcid.org/0000-0003-4012-7826","observed_orcids":["https://orcid.org/0000-0003-4012-7826"]},"institutions":[{"id":"https://openalex.org/I4210142787","display_name":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios","ror":"https://ror.org/043fs9135","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210098440","https://openalex.org/I4210142787"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Consuelo Huerta","raw_affiliation_strings":["Pharmacoepidemiology and Pharmacovigilance Division, Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacoepidemiology and Pharmacovigilance Division, Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain","institution_ids":["https://openalex.org/I4210142787"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006989637","display_name":"Elisa Mart\u00edn\u2010Merino","orcid":"https://orcid.org/0000-0002-3576-8605","observed_orcids":["https://orcid.org/0000-0002-3576-8605"]},"institutions":[{"id":"https://openalex.org/I4210142787","display_name":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios","ror":"https://ror.org/043fs9135","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210098440","https://openalex.org/I4210142787"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Elisa Martin Merino","raw_affiliation_strings":["Pharmacoepidemiology and Pharmacovigilance Division, Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacoepidemiology and Pharmacovigilance Division, Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain","institution_ids":["https://openalex.org/I4210142787"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113904087","display_name":"Dolores Montero","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142787","display_name":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios","ror":"https://ror.org/043fs9135","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210098440","https://openalex.org/I4210142787"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Dolores Montero","raw_affiliation_strings":["Pharmacoepidemiology and Pharmacovigilance Division, Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacoepidemiology and Pharmacovigilance Division, Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain","institution_ids":["https://openalex.org/I4210142787"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062891274","display_name":"Christiane Gasse","orcid":"https://orcid.org/0000-0001-6194-1099","observed_orcids":["https://orcid.org/0000-0001-6194-1099"]},"institutions":[{"id":"https://openalex.org/I2802335433","display_name":"Aarhus University Hospital","ror":"https://ror.org/040r8fr65","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802335433"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Christiane Gasse","raw_affiliation_strings":["Department for Depression and Anxiety/Psychosis Research Unit, Aarhus University Hospital Psychiatry, Aarhus, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department for Depression and Anxiety/Psychosis Research Unit, Aarhus University Hospital Psychiatry, Aarhus, Denmark","institution_ids":["https://openalex.org/I2802335433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003383445","display_name":"Morten Tolstrup Andersen","orcid":"https://orcid.org/0000-0001-7029-2860","observed_orcids":["https://orcid.org/0000-0001-7029-2860"]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Morten Andersen","raw_affiliation_strings":["Pharmacovigilance Research Centre, Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacovigilance Research Centre, Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark","institution_ids":["https://openalex.org/I124055696"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006638453","display_name":"Mia Aakj\u00e6r","orcid":"https://orcid.org/0000-0002-6381-6715","observed_orcids":["https://orcid.org/0000-0002-6381-6715"]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Mia Aakj\u00e6r","raw_affiliation_strings":["Pharmacovigilance Research Centre, Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacovigilance Research Centre, Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark","institution_ids":["https://openalex.org/I124055696"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054001832","display_name":"Marie L. De Bruin","orcid":"https://orcid.org/0000-0001-9197-7068","observed_orcids":["https://orcid.org/0000-0001-9197-7068"]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]},{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]}],"countries":["DK","NL"],"is_corresponding":false,"raw_author_name":"Marie Louise De Bruin","raw_affiliation_strings":["Copenhagen Centre of Regulatory Science (CORS), Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark","Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Copenhagen Centre of Regulatory Science (CORS), Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark","institution_ids":["https://openalex.org/I124055696"]},{"raw_affiliation_string":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I193662353"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Roman Gerlach","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I266832205","display_name":"National Association of Statutory Health Insurance Physicians","ror":"https://ror.org/02jwgg565","country_code":"DE","type":"other","lineage":["https://openalex.org/I266832205"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Roman Gerlach","raw_affiliation_strings":["National Association of Statutory Health Insurance Physicians of Bavaria, Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Association of Statutory Health Insurance Physicians of Bavaria, Munich, Germany","institution_ids":["https://openalex.org/I266832205"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061462247","display_name":"Martin Tauscher","orcid":"https://orcid.org/0009-0009-9814-4451","observed_orcids":["https://orcid.org/0009-0009-9814-4451"]},"institutions":[{"id":"https://openalex.org/I266832205","display_name":"National Association of Statutory Health Insurance Physicians","ror":"https://ror.org/02jwgg565","country_code":"DE","type":"other","lineage":["https://openalex.org/I266832205"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Martin Tauscher","raw_affiliation_strings":["National Association of Statutory Health Insurance Physicians of Bavaria, Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Association of Statutory Health Insurance Physicians of Bavaria, Munich, Germany","institution_ids":["https://openalex.org/I266832205"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084013498","display_name":"Patrick Cyriel Souverein","orcid":"https://orcid.org/0000-0002-7452-0477","observed_orcids":["https://orcid.org/0000-0002-7452-0477"]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Patrick C. Souverein","raw_affiliation_strings":["Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I193662353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046508864","display_name":"Rianne van den Ham","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Rianne van den Ham","raw_affiliation_strings":["Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I193662353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038962814","display_name":"Olaf H. Klungel","orcid":"https://orcid.org/0000-0002-5604-813X","observed_orcids":["https://orcid.org/0000-0002-5604-813X"]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Olaf Klungel","raw_affiliation_strings":["Department of Clinical Pharmacy, Division Laboratory and Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy, Division Laboratory and Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I3018483916"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071132650","display_name":"Helga Gardarsd\u00f3ttir","orcid":"https://orcid.org/0000-0001-5623-9684","observed_orcids":["https://orcid.org/0000-0001-5623-9684"]},"institutions":[{"id":"https://openalex.org/I165368041","display_name":"University of Iceland","ror":"https://ror.org/01db6h964","country_code":"IS","type":"education","lineage":["https://openalex.org/I165368041"]},{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]},{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]}],"countries":["IS","NL"],"is_corresponding":false,"raw_author_name":"Helga Gardarsdottir","raw_affiliation_strings":["Department of Clinical Pharmacy, Division Laboratory and Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands","Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands","Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavik, Iceland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy, Division Laboratory and Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I3018483916"]},{"raw_affiliation_string":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I193662353"]},{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavik, Iceland","institution_ids":["https://openalex.org/I165368041"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":12,"corresponding_author_ids":["https://openalex.org/A5039118583"],"corresponding_institution_ids":["https://openalex.org/I8204097"],"apc_list":{"value":3600,"currency":"USD","value_usd":3600},"apc_paid":null,"fwci":0.6059,"has_fulltext":true,"cited_by_count":29,"citation_normalized_percentile":{"value":0.71052072,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"128","issue":"3","first_page":"440","last_page":"454"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.9657999873161316,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.9657999873161316,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.008799999952316284,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.008200000040233135,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/direct-oral-anticoagulants","display_name":"direct oral anticoagulants","score":0.9879999756813049},{"id":"https://openalex.org/keywords/dabigatran","display_name":"dabigatran","score":0.9589999914169312},{"id":"https://openalex.org/keywords/rivaroxaban","display_name":"rivaroxaban","score":1.0},{"id":"https://openalex.org/keywords/apixaban","display_name":"apixaban","score":1.0},{"id":"https://openalex.org/keywords/summary-of-product-characteristics","display_name":"Summary of Product Characteristics","score":0.9089999794960022},{"id":"https://openalex.org/keywords/contraindications","display_name":"contraindications","score":0.8849999904632568},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.8709999918937683},{"id":"https://openalex.org/keywords/non-valvular-atrial-fibrillation","display_name":"non-valvular atrial fibrillation","score":0.9070000052452087},{"id":"https://openalex.org/keywords/medication-use","display_name":"medication use","score":0.6050000190734863},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.8220000267028809},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.578000009059906},{"id":"https://openalex.org/keywords/european-comparison","display_name":"European comparison","score":0.414000004529953}],"concepts":[{"id":"https://openalex.org/C2780638905","wikidata":"https://www.wikidata.org/wiki/Q414462","display_name":"Apixaban","level":5,"score":0.9024280309677124},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8899126648902893},{"id":"https://openalex.org/C2778810321","wikidata":"https://www.wikidata.org/wiki/Q419345","display_name":"Dabigatran","level":4,"score":0.8225500583648682},{"id":"https://openalex.org/C2778661090","wikidata":"https://www.wikidata.org/wiki/Q420262","display_name":"Rivaroxaban","level":4,"score":0.788725733757019},{"id":"https://openalex.org/C2776494729","wikidata":"https://www.wikidata.org/wiki/Q1848900","display_name":"Contraindication","level":3,"score":0.7828640341758728},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4771972596645355},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.4753408432006836},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.45751163363456726},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.43742379546165466},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3822326362133026},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.31738144159317017},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2972690761089325},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.27533936500549316},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.2208525538444519},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.12841129302978516},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.10579502582550049},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069552","descriptor_name":"Rivaroxaban","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000069552","descriptor_name":"Rivaroxaban","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000069604","descriptor_name":"Dabigatran","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000069604","descriptor_name":"Dabigatran","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000075203","descriptor_name":"Contraindications, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004363","descriptor_name":"Drug Utilization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011307","descriptor_name":"Drug Prescriptions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1111/bcpt.13517","doi":"https://doi.org/10.1111/bcpt.13517","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bcpt.13517","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcpt.13517","source":{"id":"https://openalex.org/S44074210","display_name":"Basic & Clinical Pharmacology & Toxicology","issn_l":"1742-7835","issn":["1742-7835","1742-7843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Basic & Clinical Pharmacology & Toxicology","raw_type":"journal-article"},{"id":"pmid:33037766","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33037766","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Basic & clinical pharmacology & toxicology","raw_type":"Comparative Study"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/5ece63d8-e1ff-42c1-9cbc-73d7ae5dcc8a","doi":null,"is_oa":false,"landing_page_url":"https://researchprofiles.ku.dk/da/publications/5ece63d8-e1ff-42c1-9cbc-73d7ae5dcc8a","pdf_url":null,"source":{"id":"https://openalex.org/S4306401983","display_name":"Research at the University of Copenhagen (University of Copenhagen)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I124055696","host_organization_name":"University of Copenhagen","host_organization_lineage":["https://openalex.org/I124055696"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.atira.dk:publications/f387e29d-d6a9-450b-8757-a797af6c07e8","doi":null,"is_oa":false,"landing_page_url":"https://pure.au.dk/portal/en/publications/f387e29d-d6a9-450b-8757-a797af6c07e8","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PE&PV consortium 2021, 'Prescribers' compliance with Summary of Product Characteristics of dabigatran, rivaroxaban and apixaban - a European comparative drug utilization study', Basic and Clinical Pharmacology and Toxicology, vol. 128, no. 3, pp. 440-454. https://doi.org/10.1111/bcpt.13517","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:uu:oai:dspace.library.uu.nl:1874/428439","doi":null,"is_oa":true,"landing_page_url":"https://dspace.library.uu.nl/handle/1874/428439","pdf_url":null,"source":{"id":"https://openalex.org/S4306401649","display_name":"Utrecht University Repository (Utrecht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193662353","host_organization_name":"Utrecht University","host_organization_lineage":["https://openalex.org/I193662353"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Basic & Clinical Pharmacology & Toxicology, 128(3), 440. Blackwell Publishing Ltd","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1111/bcpt.13517","doi":"https://doi.org/10.1111/bcpt.13517","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bcpt.13517","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcpt.13517","source":{"id":"https://openalex.org/S44074210","display_name":"Basic & Clinical Pharmacology & Toxicology","issn_l":"1742-7835","issn":["1742-7835","1742-7843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Basic & Clinical Pharmacology & Toxicology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[{"id":"https://openalex.org/G2889837240","display_name":null,"funder_award_id":"EMA/2015/27/PH","funder_id":"https://openalex.org/F4320327812","funder_display_name":"European Medicines Agency"},{"id":"https://openalex.org/G5559258887","display_name":null,"funder_award_id":"NFF15SA0018404","funder_id":"https://openalex.org/F4320325957","funder_display_name":"Novo Nordisk Fonden"}],"funders":[{"id":"https://openalex.org/F4320325957","display_name":"Novo Nordisk Fonden","ror":"https://ror.org/04txyc737"},{"id":"https://openalex.org/F4320327812","display_name":"European Medicines Agency","ror":"https://ror.org/01z0wsw92"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3092298396.pdf","grobid_xml":"https://content.openalex.org/works/W3092298396.grobid-xml"},"referenced_works_count":46,"referenced_works":["https://openalex.org/W826970266","https://openalex.org/W1560674932","https://openalex.org/W1757837840","https://openalex.org/W1822903338","https://openalex.org/W1829866114","https://openalex.org/W1978670003","https://openalex.org/W1987339155","https://openalex.org/W2026766534","https://openalex.org/W2034536527","https://openalex.org/W2035284622","https://openalex.org/W2080910965","https://openalex.org/W2096246254","https://openalex.org/W2097854437","https://openalex.org/W2104378767","https://openalex.org/W2119852447","https://openalex.org/W2136489990","https://openalex.org/W2142749836","https://openalex.org/W2162508946","https://openalex.org/W2164785151","https://openalex.org/W2166375212","https://openalex.org/W2219591537","https://openalex.org/W2284499677","https://openalex.org/W2410338999","https://openalex.org/W2419389447","https://openalex.org/W2471768068","https://openalex.org/W2517582840","https://openalex.org/W2537569812","https://openalex.org/W2551469077","https://openalex.org/W2560537841","https://openalex.org/W2565878672","https://openalex.org/W2566947560","https://openalex.org/W2604738434","https://openalex.org/W2623635585","https://openalex.org/W2716549597","https://openalex.org/W2724099449","https://openalex.org/W2736956220","https://openalex.org/W2741112664","https://openalex.org/W2755942710","https://openalex.org/W2764335093","https://openalex.org/W2765472879","https://openalex.org/W2769275060","https://openalex.org/W2785706643","https://openalex.org/W2799804580","https://openalex.org/W2893625141","https://openalex.org/W2911828070","https://openalex.org/W6637901446"],"related_works":["https://openalex.org/W6964887258","https://openalex.org/W3196256536","https://openalex.org/W3016646987","https://openalex.org/W3000004317","https://openalex.org/W2998479231","https://openalex.org/W7162040549","https://openalex.org/W2764335093","https://openalex.org/W2963243813","https://openalex.org/W2324508813","https://openalex.org/W6958312809"],"abstract_inverted_index":{"Despite":[0],"a":[1,100,140,232],"tremendous":[2],"increase":[3],"of":[4,23,53,151,216,235],"direct":[5],"oral":[6],"anticoagulants":[7],"(DOACs)":[8],"prescriptions":[9],"in":[10,50,93,104,132,231,262,282,293],"recent":[11],"years,":[12],"only":[13],"few":[14],"data":[15,92],"is":[16],"available":[17],"analysing":[18],"prescribers'":[19],"adherence":[20,31],"to":[21,29,32,86,199,240,254,279,291],"Summary":[22],"Product":[24],"Characteristics":[25],"(SmPC).":[26],"We":[27,65],"aimed":[28],"assess":[30],"registered":[33],"indications,":[34],"contraindications,":[35],"special":[36,166,195,223],"warnings/precautions,":[37,224],"and":[38,48,63,75,116,170,225],"potential":[39,175,226],"drug-drug":[40,176,227],"interactions":[41,228],"for":[42,244,250,257],"three":[43],"DOAC":[44,101,237],"compounds":[45],"(dabigatran,":[46],"rivaroxaban,":[47],"apixaban)":[49],"six":[51],"databases":[52,145,264,275],"five":[54],"European":[55],"countries":[56],"(The":[57],"Netherlands,":[58],"United":[59],"Kingdom,":[60],"Spain,":[61],"Denmark,":[62],"Germany).":[64],"included":[66],"adult":[67],"patients":[68,107,152],"(\u226518":[69],"years)":[70],"initiating":[71],"DOACs":[72],"between":[73,143,274],"2008":[74],"2015.":[76],"For":[77,135],"several":[78],"SmPC":[79,88,246,259],"items,":[80],"broad":[81,241],"definitions":[82,242],"were":[83,229],"used":[84,243],"due":[85,290],"ambiguous":[87],"terms":[89,260],"or":[90],"lacking":[91],"some":[94,245],"databases.":[95],"Within":[96],"the":[97,127,136,144,149,182,192,200,263,266],"study":[98,138],"period,":[99,139],"was":[102,126,146,186,197,213],"initiated":[103],"407":[105],"576":[106],"(rivaroxaban:":[108],"240":[109],"985":[110],"(59.1%),":[111],"dabigatran:":[112],"95":[113],"303":[114],"(23.4%),":[115],"apixaban:":[117],"71":[118],"288":[119],"(17.5%)).":[120],"In":[121,180],"2015,":[122,181],"non-valvular":[123],"atrial":[124],"fibrillation":[125],"most":[128,133,183,193,207],"common":[129,208],"indication":[130],"(>60%":[131],"databases).":[134],"whole":[137],"substantial":[141],"variation":[142],"found":[147],"regarding":[148],"proportion":[150],"with":[153,162,171],"at":[154,163,172],"least":[155,164,173],"one":[156,165,174],"contraindication":[157,185],"(inter-database":[158],"range":[159],"[IDR]:":[160],"8.2%-55.7%),":[161],"warning/precaution":[167,196],"(IDR:":[168,178,189,220],"35.8%-75.2%)":[169],"interaction":[177,212],"22.4%-54.1%).":[179],"frequent":[184,194],"\"malignant":[187],"neoplasm\"":[188],"0.7%-21.3%)":[190],"whereas":[191],"\"prescribing":[198],"elderly\"":[201],"(\u226575":[202],"years;":[203],"IDR:":[204],"25.0%-66.4%).":[205],"The":[206],"single":[209],"compound":[210],"class":[211],"\"concomitant":[214],"use":[215],"non-steroidal":[217],"anti-inflammatory":[218],"drugs\"":[219],"3.0%-25.3%).":[221],"Contraindications,":[222],"present":[230],"relevant":[233],"number":[234],"new":[236],"users.":[238],"Due":[239],"terms,":[247],"overall":[248],"proportions":[249],"contraindications":[251],"are":[252],"prone":[253],"overestimation.":[255],"However,":[256],"unambiguous":[258],"documented":[261],"sufficiently,":[265],"respective":[267],"estimates":[268],"can":[269],"be":[270,277,288],"considered":[271],"valid.":[272],"Differences":[273],"might":[276],"related":[278],"\"true\"":[280],"differences":[281,292],"prescription":[283],"behaviour,":[284],"but":[285],"could":[286],"also":[287],"partially":[289],"database":[294],"characteristics.":[295]},"counts_by_year":[{"year":2025,"cited_by_count":25},{"year":2023,"cited_by_count":3},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-10-15T00:00:00"}